Li, C. 2026. Should CRISPR-Cas9 Be Used in Human Embryos to Eliminate Genetic Diseases? Public Attitudes and Benefit–Risk Analysis. MedScien. 4, 1 (Feb. 2026), 6812. DOI:https://doi.org/10.61173/as39n470.